Author:
Aoyama Keiichi,Tsukishiro Takashi,Okada Kazuhiro,Tsuchida Toshihiro,Aiba Nobuyasu,Nambu Shuji,Miyabayashi Chiharu,Yasuyama Toshifumi,Higuchi Kiyohiro,Watanabe Akiharu
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference7 articles.
1. Arcamone F, Penco S, Vigevani A, Redaelli S, Franchi G (1975) Synthesis and antitumor properties of new glycosides of daunomycinone and Adriamycinone. J Med Chem 18: 703
2. Konno T, Maeda H, Iwaki K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T, Yokoyama I (1983) Effect of arterial administration of high-molecular-weight anti-cancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 19: 1053
3. Liver Cancer Study Group of Japan (1983) The general rules for the clinical and pathological study of primary liver cancer (in Japanese). Kanchara Shuppan, Tokyo
4. Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, Matsuo N, Hosogi Y (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154: 25
5. Ueno M, Wakamatsu N, Yoshimatsu K, Ishizuka Y, Horikoshi I, Abe Y (1986) Control release of Adriamycin from water-in-lipiodol emulsion and a comment on the measurement of drug release. Jpn J Cancer Chemother 13: 3291